Completed Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old NCT05518201 Conditions AIN1, AIN2, AIN3, +44 more Locations Center for Disease Control and Prevention — Mianzhu, Sichuan, China View Trial Details
